rofecoxib has been researched along with Breast Neoplasms in 5 studies
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a case-control study to measure the association between selective cox-2 inhibitors, particularly celecoxib, rofecoxib, valdecoxib and non-specific NSAID subgroups, and breast cancer risk." | 3.77 | Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk. ( Ashok, V; Dash, C; Rohan, TE; Sprafka, JM; Terry, PD, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sangjun, S | 1 |
| de Jong, E | 1 |
| Nijmeijer, S | 1 |
| Mutarapat, T | 1 |
| Ruchirawat, S | 1 |
| van den Berg, M | 1 |
| van Duursen, MB | 1 |
| Ashok, V | 1 |
| Dash, C | 1 |
| Rohan, TE | 1 |
| Sprafka, JM | 1 |
| Terry, PD | 1 |
| Hegi, TR | 1 |
| Bombeli, T | 1 |
| Seifert, B | 1 |
| Baumann, PC | 1 |
| Haller, U | 1 |
| Zalunardo, MP | 1 |
| Pasch, T | 1 |
| Spahn, DR | 1 |
| Thompson, CA | 1 |
| Hval, K | 1 |
| Kjetil, H | 1 |
| Thagaard, KS | 1 |
| Sem, TK | 1 |
| Schlichting, E | 1 |
| Ellen, S | 1 |
| Raeder, J | 1 |
| Johan, R | 1 |
2 trials available for rofecoxib and Breast Neoplasms
| Article | Year |
|---|---|
Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Blood Loss, S | 2004 |
The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Dexamethasone; Double-Blind Method | 2007 |
3 other studies available for rofecoxib and Breast Neoplasms
| Article | Year |
|---|---|
Induction of cell cycle arrest in human MCF-7 breast cancer cells by cis-stilbene derivatives related to VIOXX.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Su | 2009 |
Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; | 2011 |
COX-2 inhibitors still eyed for cancer prevention.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Celecoxib; Colonic Neoplasms; Cycl | 2005 |